Reacción a "A study involving 100,000 people shows that they all carry genetic variants that may influence their response to medicines"

The article is of great interest as it confirms, based on the largest number of patients to date, what all of us working in pharmacogenetics already knew: we are all carriers of some variant that may be useful in improving the efficacy and/or safety of medicines we are already taking or may take throughout our lives.

High-quality studies such as this one, carried out under a reputable initiative such as All of Us, can provide part of the impetus needed for both doctors and patients to understand the importance of pharmacogenetics and to capitalise on the enormous advantage we have in Spain, as we are pioneers in Europe in including pharmacogenetic tests in the catalogue of our public health system.